Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly.
Chouraki V, De Bruijn RF, Chapuis J, Bis JC, Reitz C, Schraen S, Ibrahim-Verbaas CA, Grenier-Boley B, Delay C, Rogers R, Demiautte F, Mounier A, Fitzpatrick AL; Alzheimer's Disease Neuroimaging Initiative; Berr C, Dartigues JF, Uitterlinden AG, Hofman A, Breteler M, Becker JT, Lathrop M, Schupf N, Alpérovitch A, Mayeux R, van Duijn CM, Buée L, Amouyel P, Lopez OL, Ikram MA, Tzourio C, Lambert JC. Chouraki V, et al. Among authors: schraen s. Mol Psychiatry. 2014 Dec;19(12):1326-35. doi: 10.1038/mp.2013.185. Epub 2014 Feb 18. Mol Psychiatry. 2014. PMID: 24535457 Free PMC article.
Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants.
Damotte V, van der Lee SJ, Chouraki V, Grenier-Boley B, Simino J, Adams H, Tosto G, White C, Terzikhan N, Cruchaga C, Knol MJ, Li S, Schraen S, Grove ML, Satizabal C, Amin N, Berr C, Younkin S; Alzheimer's Disease Neuroimaging Initiative; Gottesman RF, Buée L, Beiser A, Knopman DS, Uitterlinden A, DeCarli C, Bressler J, DeStefano A, Dartigues JF, Yang Q, Boerwinkle E, Tzourio C, Fornage M, Ikram MA, Amouyel P, de Jager P, Reitz C, Mosley TH, Lambert JC, Seshadri S, van Duijn CM. Damotte V, et al. Among authors: schraen s. Alzheimers Dement. 2021 Oct;17(10):1663-1674. doi: 10.1002/alz.12333. Epub 2021 May 18. Alzheimers Dement. 2021. PMID: 34002480 Free PMC article.
Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease.
Bensemain F, Hot D, Ferreira S, Dumont J, Bombois S, Maurage CA, Huot L, Hermant X, Levillain E, Hubans C, Hansmannel F, Chapuis J, Hauw JJ, Schraen S, Lemoine Y, Buée L, Berr C, Mann D, Pasquier F, Amouyel P, Lambert JC. Bensemain F, et al. Among authors: schraen s. Mol Psychiatry. 2009 Jan;14(1):106-16. doi: 10.1038/sj.mp.4002089. Epub 2007 Sep 25. Mol Psychiatry. 2009. PMID: 17893704
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
Dumurgier J, Sabia S, Zetterberg H, Teunissen CE, Hanseeuw B, Orellana A, Schraen S, Gabelle A, Boada M, Lebouvier T, Willemse EAJ, Cognat E, Ruiz A, Hourregue C, Lilamand M, Bouaziz-Amar E, Laplanche JL, Lehmann S, Pasquier F, Scheltens P, Blennow K, Singh-Manoux A, Paquet C; Alzheimer's Disease Neuroimaging Initiative. Dumurgier J, et al. Among authors: schraen s. Neurology. 2022 Aug 16;99(7):e669-e678. doi: 10.1212/WNL.0000000000200735. Epub 2022 May 26. Neurology. 2022. PMID: 35970577 Free PMC article.
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
Bousiges O, Bombois S, Schraen S, Wallon D, Quillard MM, Gabelle A, Lehmann S, Paquet C, Amar-Bouaziz E, Magnin E, Miguet-Alfonsi C, Delbeuck X, Lavaux T, Anthony P, Philippi N, Blanc F; ePLM network and collaborators. Bousiges O, et al. Among authors: schraen s. J Neurol Neurosurg Psychiatry. 2018 May;89(5):467-475. doi: 10.1136/jnnp-2017-316385. Epub 2018 Jan 10. J Neurol Neurosurg Psychiatry. 2018. PMID: 29321140
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.
Lehmann S, Schraen S, Quadrio I, Paquet C, Bombois S, Delaby C, Dorey A, Dumurgier J, Hirtz C, Krolak-Salmon P, Laplanche JL, Moreaud O, Peoc'h K, Rouaud O, Sablonnière B, Thouvenot E, Touchon J, Vercruysse O, Hugon J, Gabelle A, Pasquier F, Perret-Liaudet A. Lehmann S, et al. Among authors: schraen s. Alzheimers Dement. 2014 Oct;10(5 Suppl):S390-S394.e2. doi: 10.1016/j.jalz.2013.06.008. Epub 2013 Oct 23. Alzheimers Dement. 2014. PMID: 24269268
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study.
Moreau C, Delval A, Tiffreau V, Defebvre L, Dujardin K, Duhamel A, Petyt G, Hossein-Foucher C, Blum D, Sablonnière B, Schraen S, Allorge D, Destée A, Bordet R, Devos D. Moreau C, et al. Among authors: schraen s. J Neurol Neurosurg Psychiatry. 2013 May;84(5):552-5. doi: 10.1136/jnnp-2012-303182. Epub 2012 Oct 16. J Neurol Neurosurg Psychiatry. 2013. PMID: 23077087 Free PMC article. Clinical Trial.
44 results